Coalition for Affordable Drugs V LLC v. Biogen Idec Ma Inc

Robert Hahl

Biogen's multiple sclerosis patent challenged: all 20 claims for a 480mg DMF dose argued as obvious over prior art showing efficacy at a higher dose.

Judge	Cases	Inst. Rate	FWD Inv. Rate
Deborah Katz	60+	80%	89%
Fred E McKelvey	40+	69%	68%
Richard E Schafer	3	100%	33%

Name	Ratings
Coalition for Affordable Drugs V LLC	L1D
nXn Partners LLC	L1B
J Kyle Bass	L1B
Erich Spangenberg	L1B
Hayman Orange Fund SPC Portfolio A	L1D
IP Navigation Group LLC	L1D
Hayman Credes Master Fund LP	L1D

Name	Ratings
Finnegan Henderson Farabow Garrett & Dunner LLP	L5A
Michael J. Flibbert	L3B
Maureen Queler	L3B
Erin Sommers	L2D